Renal Denervation in Hypertension

Summary

Renal Denervation in Hypertension is a clinical trial^[1].

Key Facts

• Renal Denervation in Hypertension is in the country of France^[2].
• Renal Denervation in Hypertension's instance of is recorded as clinical trial^[3].
• Renal Denervation in Hypertension's start time is recorded as +2012-04-30T00:00:00Z^[4].
• Renal Denervation in Hypertension's end time is recorded as +2014-05-31T00:00:00Z^[5].
• Renal Denervation in Hypertension's sponsor is recorded as Assistance Publique – Hôpitaux de Paris^[6].
• Renal Denervation in Hypertension's main subject is recorded as essential hypertension^[7].
• Renal Denervation in Hypertension's main subject is recorded as arterial hypertension^[8].
• Renal Denervation in Hypertension's number of participants is recorded as {'unit': '1', 'amount': '+121'}^[9].
• Renal Denervation in Hypertension's title is recorded as Renal Denervation in Patients With Resistant Hypertension^[10].
• Renal Denervation in Hypertension's short name is recorded as DENER-HTN^[11].
• Renal Denervation in Hypertension's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Renal Denervation in Hypertension's ClinicalTrials.gov ID is recorded as NCT01570777^[13].
• Renal Denervation in Hypertension's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[14].
• Renal Denervation in Hypertension's clinical trial phase is recorded as phase IV clinical trial^[15].
• Renal Denervation in Hypertension's research subject recruitment status is recorded as completed^[16].
• Renal Denervation in Hypertension's study type is recorded as interventional study^[17].